oxi4503
Generic: Combretastatin A1-diphsphate (CA1P)·Code: CA1P
oxi4503: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Oncotelic Therapeutics, Inc. (OTLC) | Phase 2 |
Get deeper analysis on oxi4503
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis